Lifecore Biomedical
(NASDAQ:LFCR)
$6.00
0.01[0.17%]
Last update: 4:00PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Lifecore Biomedical Stock (NASDAQ:LFCR), Quotes and News Summary

Lifecore Biomedical Stock (NASDAQ: LFCR) stock price, news, charts, stock research, profile.

Open$5.960
Close-
Volume / Avg.56.286K / 196.961K
Day Range5.960 - 6.050
52 Wk Range4.130 - 11.455
Market Cap$183.282M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
42
Short Interest
9.39%
Days to Cover13.65

Recent News

Dow Surges 350 Points; Fed Holds Rates Steady
U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also rose, gaining, 0.78% to 5,218.70.
Avi Kapoor
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.
Avi Kapoor
Crude Oil Dips 2%; Signet Jewelers Shares Spike Higher
U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P 500 also rose, gaining, 0.01% to 5,178.79.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
2.4
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LFCR
HBIO

FAQ

Q

How do I buy Lifecore Biomedical (LFCR) stock?

A

You can purchase shares of Lifecore Biomedical (NASDAQ: LFCR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lifecore Biomedical's (LFCR) competitors?

A

Other companies in Lifecore Biomedical’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Quanterix (NASDAQ:QTRX), Conduit Pharmaceuticals (NASDAQ:CDT) and ChromaDex (NASDAQ:CDXC).

Q

What is the target price for Lifecore Biomedical (LFCR) stock?

A

The latest price target for Lifecore Biomedical (NASDAQ: LFCR) was reported by Barrington Research on Friday, September 1, 2023. The analyst firm set a price target for 10.00 expecting LFCR to rise to within 12 months (a possible 65.56% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lifecore Biomedical (LFCR)?

A

The stock price for Lifecore Biomedical (NASDAQ: LFCR) is $6.04 last updated Today at May 16, 2024 at 11:32 AM EDT.

Q

Does Lifecore Biomedical (LFCR) pay a dividend?

A

There are no upcoming dividends for Lifecore Biomedical.

Q

When is Lifecore Biomedical (NASDAQ:LFCR) reporting earnings?

A

Lifecore Biomedical’s Q3 earnings are confirmed for Thursday, May 30, 2024.

Q

Is Lifecore Biomedical (LFCR) going to split?

A

There is no upcoming split for Lifecore Biomedical.

Q

What sector and industry does Lifecore Biomedical (LFCR) operate in?

A

Lifecore Biomedical is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

People Also Watch